Discontinuation of first-line disease-modifying therapy in multiple sclerosisE. M. Coerver, A. Bourass, M. H. Wessels,Z. L. Van Kempen, B. Jasperse,F. Barkhof, J. Mostert,B. M. Uitdehaag, J. Killestein,E. M. StrijbisMULTIPLE SCLEROSIS JOURNAL(2022)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要